Chimeric Protein Combining Recognition and Lysis Elements for Pathogen Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The widespread use of antibiotics has led to the rapid emergence of antibiotic resistance in both gram-positive and gram-negative bacteria, limiting their clinical use, and there is no effective treatment for diseases caused by Xylella fastidiosa (Xf) such as Pierce's Disease in grapevines.
Innovation Solution
A chimeric protein is developed comprising a recognition element and a lysis element connected by a linker, where the recognition element binds to a surface protein on the pathogen and the lysis element lyzes the pathogen. The recognition element is derived from a subtilisin or BPI/LBP protein, and the lysis element is derived from a defensin or thionin protein, both of which are endogenous to the host plant.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to target bacterial genes, then bacterial infections can be cleared, but antibiotic resistance rapidly emerges limiting clinical use
Solution Approach 1:
The antibacterial agent is divided into two functional segments: a recognition element (derived from subtilisin or BPI/LBP) that specifically binds to bacterial surface proteins, and a lysis element (derived from defensin or thionin) that creates pores in the bacterial membrane. This segmentation allows the recognition element to guide the lysis element to the target, providing specificity that prevents resistance development while maintaining effective killing activity.
Solution Approach 2:
The invention creates a chimeric protein combining two naturally occurring antibacterial components with different functions. The recognition element provides target-specific binding while the lysis element provides membrane disruption activity. This composite structure leverages the complementary strengths of both elements to achieve effective and resistant antibacterial action.
2Reliability
If antimicrobial peptides are used to disrupt bacterial membranes, then bacterial growth is inhibited, but bacteria can develop resistance by modifying membrane glycolipid components
Solution Approach 1:
The antibacterial agent is divided into two functional segments: a recognition element (derived from subtilisin or BPI/LBP) that specifically binds to bacterial surface proteins, and a lysis element (derived from defensin or thionin) that creates pores in the bacterial membrane. This segmentation allows the recognition element to guide the lysis element to the target, providing specificity that prevents resistance development while maintaining effective killing activity.
3Device complexity
If a single functional protein is used for pathogen targeting, then the mechanism is simple, but specificity and effectiveness are limited
Solution Approach 1:
The invention merges two naturally occurring antibacterial protein elements into a single chimeric protein structure. The recognition element (subtilisin or BPI/LBP) provides specific binding to bacterial surface proteins, while the lysis element (defensin or thionin) provides membrane disruption activity. This merging creates a unified protein that combines both functions, achieving high targeting effectiveness while maintaining relatively simple single-protein structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The chimeric protein effectively targets and kills Xf bacteria, providing increased resistance to bacterial infections in genetically altered plants and offering a potential treatment for diseases caused by Xf.
Implementation Method 1
the recognition element binds to a surface protein on the pathogen
Implementation Method 2
the lysis element lyses the pathogen
Data Source
AI summary
A chimeric protein and method of creating genetically altered plant and parts thereof with a chimeric protein wherein the chimeric protein comprises a recognition element and a lysis element connected by a linker wherein the recognition element binds to a pathogen and the lysis element lyses the pathogen and wherein the recognition element is derived from a first protein and the lysis element is derived from a second protein wherein the first protein and the second protein are endogenous to the host to be treated with the chimeric protein.


